VIE/AVTR (VIE/AVTR)

Vienna Stock Exchange: VIE/AVTR · EUR

€14.6

-0.87 (-5.7%)· Recorded snapshot

Market cap	10.1B
Revenue (ttm)	5.8B
Net income (ttm)	296.9M
EPS (ttm)	€0.45
P/E (trailing)	32.6x
P/E (forward)	19.1x

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 5.8B
Net income (ttm): 296.9M
EPS (ttm): €0.45
P/E (trailing): 32.6x
P/E (forward): 19.1x
Market cap: 10.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E19.1

P25 14.3P50 18.7P75 25.4

Trailing P/E32.6

P25 20.4P50 26.7P75 39.7

ROE5.9

P25 4.8P50 10.6P75 20.1

ROIC5.8

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

All VIE/AVTR indicators

Market & fundamental data

Available fields

221

Groups with data

Currency

USD

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	AT
Earnings date	2026-10-28
Employees	13,500
Employees change	-1,000
Employees growth	-6.9%
Enterprise value	EUR 13B
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1904
Industry	Medical Instruments & Supplies
Is primary listing	No
ISIN number	US05352A1007
Last earnings date	2026-10-28
Last refreshed	2026-10-29
Market cap	EUR 10.1B
Next earnings date	2026-10-30
Price	EUR 14.61
Price currency	EUR
Sector	Healthcare
SIC code	3826
Stock price date	2026-10-28
Symbol	vie/AVTR
Website	https://www.avantorsciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	36.35x
Average P/E ratio (5Y)	34.5x
Earnings yield	3.06%
EV/Earnings	43.9x
EV/EBIT	27.5x
EV/EBITDA	14.42x
EV/FCF	33.7x
EV/Sales	2.19x
FCF / EV yield	2.97%
FCF yield	3.81%
Forward P/E	19.14x
Graham number	8.43413
Graham upside	-42.25%
Lynch fair value	EUR 2.14
Lynch upside	-85.37%
P/(FCF - SBC) ratio	29.44x
P/(OCF - SBC) ratio	21.46x
P/B ratio	1.97x
P/E ratio	32.64x
P/FCF ratio	26.24x
P/OCF ratio	19.71x
P/S ratio	1.74x
Price/EBITDA ratio	12.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	7.96%
EBITDA margin	14.28%
FCF margin	6.49%
Gross margin	31.59%
Operating margin	7.96%
Pretax margin	4.75%
Profit margin	5.08%
Profit per employee	EUR 21,995
Profitable quarters	3
Revenue per employee	EUR 432,838
ROA	2.83%
ROA (5Y)	4.37%
ROCE	5.15%
ROE	5.91%
ROE (5Y)	8.34%
ROIC	5.85%
ROIC (5Y)	7.18%
SBC / revenue	0.72%
Tax / revenue	-0.33%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (QoQ)	432.44%
EPS growth 3Y	-2.61%
EPS growth 5Y	-8.84%
EPS growth years	0
FCF growth	-16.12%
FCF growth (Q)	-9.03%
FCF growth (QoQ)	11.1%
FCF growth 3Y	-14.17%
FCF growth 5Y	-12.72%
Gross profit growth	-3.76%
Gross profit growth (Q)	1.58%
Gross profit growth 3Y	-4.51%
Gross profit growth 5Y	-2.96%
Net income growth (QoQ)	433.86%
Net income growth 3Y	-2.54%
Net income growth 5Y	-6.25%
Net income growth years	0
OCF growth	-9.26%
OCF growth (Q)	-5.93%
OCF growth (QoQ)	9.48%
OCF growth 3Y	-10.81%
OCF growth 5Y	-9.41%
Operating income growth	-24.34%
Operating income growth (Q)	0.94%
Operating income growth 3Y	-17.41%
Operating income growth 5Y	-11.89%
Revenue growth	0.92%
Revenue growth (Q)	4.59%
Revenue growth (QoQ)	0.35%
Revenue growth 3Y	-1.95%
Revenue growth 5Y	-1.81%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -128.1M
Depreciation and amortization	EUR 376.5M
EBIT	EUR 465.3M
EBITDA	EUR 834.5M
EPS	EUR 0.45
Financing cash flow	EUR -191.2M
Free cash flow	EUR 386.8M
Free cash flow minus SBC	EUR 344.7M
Gross profit	EUR 1.8B
Income taxes	EUR -19.1M
Investing cash flow	EUR -130.5M
Net borrowing	EUR -121.9M
Net cash flow	EUR 187.1M
Net income	EUR 296.9M
Operating cash flow minus SBC	EUR 472.8M
Operating income	EUR 465.3M
Revenue	EUR 5.8B
Stock-based compensation	EUR 42.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.86
Book value per share	EUR 7.58
Debt / EBITDA	3.66
Debt / equity	0.63
Debt / FCF	8.39
Goodwill	EUR 4.4B
Interest coverage	2.49
Long-term assets	EUR 7.9B
Long-term liabilities	EUR 3.9B
Net cash (debt)	EUR -2.8B
Net cash / market cap	-27.94%
Net debt / EBITDA	3.4
Net debt / equity	0.55
Net debt / FCF	7.33
Piotroski F-Score	6
Property, plant and equipment	EUR 699.5M
Shareholders' equity	EUR 5.1B
Tangible book value	EUR -1.8B
Tangible book value per share	EUR -2.63
Total assets	EUR 10.2B
Total cash	EUR 408.9M
Total debt	EUR 3.2B
Total liabilities	EUR 5.1B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.57
Current assets	EUR 2.3B
Current liabilities	EUR 1.2B
Current ratio	1.89
Inventory turnover	5.5
Net working capital	EUR 699.5M
Quick ratio	1.16
Working capital	EUR 1.1B
Working capital turnover	5.95

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.49%
Shareholder yield	0.49%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 10.08
1D price change	-5.65%
1M price change	8.75%
1M total return	8.75%
1W price change	-0.98%
1W total return	-0.98%
1Y price change	12.35%
1Y return CAGR	12.36%
1Y total return	12.35%
20-day SMA	EUR 14.27
200-day SMA	EUR 9.71
3M price change	40.98%
3M total return	40.98%
3Y price change	-17.34%
3Y return CAGR	-6.15%
3Y total return	-17.34%
50-day SMA	EUR 13.43
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 15.66
52-week high date	2026-10-27
52-week low	EUR 6.44
52-week low date	2026-04-29
5Y price change	-54.64%
5Y return CAGR	-14.63%
5Y total return	-54.64%
6M price change	116.5%
6M total return	116.5%
All-time high	EUR 37.80
All-time high date	2021-09-16
All-time low	EUR 6.44
All-time low date	2026-04-29
Average true range (ATR)	EUR 0.34
Average volume	0
Change from 52-week high	-6.71%
Change from 52-week low	126.65%
Change from all-time high	-61.36%
Change from all-time low	126.64%
Change from open	-4.54%
Day's gap	-1.16%
High price	EUR 15.30
Low price	EUR 14.61
Monthly RSI	54.74
Open price	EUR 15.30
Position in 52-week range	0%
Previous close	EUR 15.48
Price vs 150-day SMA	44.83%
Price vs 20-day SMA	2.33%
Price vs 200-day SMA	50.49%
Price vs 50-day SMA	8.77%
Relative volume	3.41
RSI	57.3
Sharpe ratio	0.33
Sharpe ratio (3Y)	-0.04
Sharpe ratio (5Y)	-0.26
Sortino ratio	0.56
Sortino ratio (3Y)	0.06
Sortino ratio (5Y)	-0.23
Weekly RSI	72.69
YTD price change	50.57%
YTD total return	50.57%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	657.8M
Shares change (QoQ)	0.55%
Shares change (YoY)	-0.49%
Shares held by insiders	0.58%
Shares held by institutions	102.07%
Short ratio	3.7 days

Deeper analysis on VIE/AVTR

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/AVTR report

Is a complete VIE/AVTR research report available?

No complete published report is available for vie/AVTR (VIE/AVTR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/AVTR (VIE/AVTR)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/AVTR

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All VIE/AVTR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/AVTR

Frequently asked questions